Human Umbilical Cord Mesenchymal Stem Cells Attenuate Abdominal Aortic Aneurysm Progression in Sprague-Dawley Rats: Implication of Vascular Smooth Muscle Cell Phenotypic Modulation

Overview

Journal Stem Cells Dev

Date 2020 Jun 4

PMID 32486904

Citations 13

Authors

Hao Wen

Mingjing Wang

Shiqiang Gong

Xintong Li

Jinze Meng

Jie Wen

Yifei Wang

Shuqing Zhang

Shijie Xin

Affiliations

Soon will be listed here.

Abstract

Abdominal aortic aneurysm (AAA) is life-threatening, for which efficient nonsurgical treatment strategy has not been available so far. Several previous studies investigating the therapeutic effect of mesenchymal stem cells (MSCs) in AAA indicated that MSCs could inhibit aneurysmal inflammatory responses and extracellular matrix destruction, and suppress aneurysm occurrence and expansion. Vascular smooth muscle cell (VSMC) phenotypic plasticity is reported to be predisposed in AAA initiation and progression. However, little is known about the effect of MSCs on VSMC phenotypic modulation in AAA. In this study, we investigate the therapeutic efficacy of umbilical cord mesenchymal stem cells (UC-MSCs) in elastase-induced AAA model and evaluate the effect of UC-MSC on VSMC phenotypic regulation. We demonstrate that the intravenous injection of UC-MSC attenuates elastase-induced aneurysmal expansion, reduces elastin degradation and fragmentation, inhibits MMPs and TNF-α expression, and preserves and/or restores VSMC contractile phenotype in AAA. Taken together, these results highlight the therapeutic and VSMC phenotypic modulation effects of UC-MSC in AAA progression, which further indicates the potential of applying UC-MSC as an alternative treatment candidate for AAA.

Citing Articles

A Single Injection of ADRCs Does Not Prevent AAA Formation in Rats in a Randomized Blinded Design.

Kavaliunaite E, Dhumale P, Jensen C, Sheikh S, Lindholt J, Stubbe J Int J Mol Sci. 2024; 25(14).

PMID: 39062833 PMC: 11276694. DOI: 10.3390/ijms25147591.

Understanding genomic medicine for thoracic aortic disease through the lens of induced pluripotent stem cells.

Singh A, Shetty D, Jacob A, Bayraktar S, Sinha S Front Cardiovasc Med. 2024; 11:1349548.

PMID: 38440211 PMC: 10910110. DOI: 10.3389/fcvm.2024.1349548.

Promising Novel Therapies in the Treatment of Aortic and Visceral Aneurysms.

Stougiannou T, Christodoulou K, Georgakarakos E, Mikroulis D, Karangelis D J Clin Med. 2023; 12(18).

PMID: 37762818 PMC: 10531975. DOI: 10.3390/jcm12185878.

Novel pharmacological approaches in abdominal aortic aneurysm.

Puertas-Umbert L, Almendra-Pegueros R, Jimenez-Altayo F, Sirvent M, Galan M, Martinez-Gonzalez J Clin Sci (Lond). 2023; 137(15):1167-1194.

PMID: 37559446 PMC: 10415166. DOI: 10.1042/CS20220795.

A review of current status of cell-based therapies for aortic aneurysms.

Yamawaki-Ogata A, Mutsuga M, Narita Y Inflamm Regen. 2023; 43(1):40.

PMID: 37544997 PMC: 10405412. DOI: 10.1186/s41232-023-00280-8.

References

Allaire E, Muscatelli-Groux B, Guinault A, Pages C, Goussard A, Mandet C . Vascular smooth muscle cell endovascular therapy stabilizes already developed aneurysms in a model of aortic injury elicited by inflammation and proteolysis. Ann Surg. 2004; 239(3):417-27. PMC: 1356242. DOI: 10.1097/01.sla.0000114131.79899.82. View

Allahverdian S, Chaabane C, Boukais K, Francis G, Bochaton-Piallat M . Smooth muscle cell fate and plasticity in atherosclerosis. Cardiovasc Res. 2018; 114(4):540-550. PMC: 5852505. DOI: 10.1093/cvr/cvy022. View

Hulsmans M, Nahrendorf M . Proliferative, degradative smooth muscle cells promote aortic disease. J Clin Invest. 2020; 130(3):1096-1098. PMC: 7269557. DOI: 10.1172/JCI134019. View

Golledge J . Abdominal aortic aneurysm: update on pathogenesis and medical treatments. Nat Rev Cardiol. 2018; 16(4):225-242. DOI: 10.1038/s41569-018-0114-9. View

Dahal S, Swaminathan G, Carney S, Broekelmann T, Mecham R, Ramamurthi A . Pro-elastogenic effects of mesenchymal stem cell derived smooth muscle cells in a 3D collagenous milieu. Acta Biomater. 2020; 105:180-190. DOI: 10.1016/j.actbio.2020.01.030. View

Sharma A, Lu G, Jester A, Johnston W, Zhao Y, Hajzus V . Experimental abdominal aortic aneurysm formation is mediated by IL-17 and attenuated by mesenchymal stem cell treatment. Circulation. 2012; 126(11 Suppl 1):S38-45. PMC: 3448933. DOI: 10.1161/CIRCULATIONAHA.111.083451. View

Deng Y, Yi S, Wang G, Cheng J, Zhang Y, Chen W . Umbilical cord-derived mesenchymal stem cells instruct dendritic cells to acquire tolerogenic phenotypes through the IL-6-mediated upregulation of SOCS1. Stem Cells Dev. 2014; 23(17):2080-92. DOI: 10.1089/scd.2013.0559. View

Basalyga D, Simionescu D, Xiong W, Baxter B, Starcher B, Vyavahare N . Elastin degradation and calcification in an abdominal aorta injury model: role of matrix metalloproteinases. Circulation. 2004; 110(22):3480-7. PMC: 1262646. DOI: 10.1161/01.CIR.0000148367.08413.E9. View

Hellenthal F, Buurman W, Wodzig W, Schurink G . Biomarkers of AAA progression. Part 1: extracellular matrix degeneration. Nat Rev Cardiol. 2009; 6(7):464-74. DOI: 10.1038/nrcardio.2009.80. View

10.

Lesauskaite V, Epistolato M, Castagnini M, Urbonavicius S, Tanganelli P . Expression of matrix metalloproteinases, their tissue inhibitors, and osteopontin in the wall of thoracic and abdominal aortas with dilatative pathology. Hum Pathol. 2006; 37(8):1076-84. DOI: 10.1016/j.humpath.2006.03.017. View

11.

Dabrowski F, Burdzinska A, Kulesza A, Sladowska A, Zolocinska A, Gala K . Comparison of the paracrine activity of mesenchymal stem cells derived from human umbilical cord, amniotic membrane and adipose tissue. J Obstet Gynaecol Res. 2017; 43(11):1758-1768. DOI: 10.1111/jog.13432. View

12.

Warner S, Libby P . Human vascular smooth muscle cells. Target for and source of tumor necrosis factor. J Immunol. 1989; 142(1):100-9. View

13.

Yao F, Yao Z, Zhong T, Zhang J, Wang T, Zhang B . Imatinib prevents elastase-induced abdominal aortic aneurysm progression by regulating macrophage-derived MMP9. Eur J Pharmacol. 2019; 860:172559. DOI: 10.1016/j.ejphar.2019.172559. View

14.

Sakalihasan N, Michel J, Katsargyris A, Kuivaniemi H, Defraigne J, Nchimi A . Abdominal aortic aneurysms. Nat Rev Dis Primers. 2018; 4(1):34. DOI: 10.1038/s41572-018-0030-7. View

15.

Powell J, Sweeting M, Ulug P, Blankensteijn J, Lederle F, Becquemin J . Meta-analysis of individual-patient data from EVAR-1, DREAM, OVER and ACE trials comparing outcomes of endovascular or open repair for abdominal aortic aneurysm over 5 years. Br J Surg. 2017; 104(3):166-178. PMC: 5299468. DOI: 10.1002/bjs.10430. View

16.

Saulnier N, Viguier E, Perrier-Groult E, Chenu C, Pillet E, Roger T . Intra-articular administration of xenogeneic neonatal Mesenchymal Stromal Cells early after meniscal injury down-regulates metalloproteinase gene expression in synovium and prevents cartilage degradation in a rabbit model of osteoarthritis. Osteoarthritis Cartilage. 2014; 23(1):122-33. DOI: 10.1016/j.joca.2014.09.007. View

17.

Wang S, Green L, Gutwein A, Drucker N, Motaganahalli R, Fajardo A . Rationale and Design of the ARREST Trial Investigating Mesenchymal Stem Cells in the Treatment of Small Abdominal Aortic Aneurysm. Ann Vasc Surg. 2017; 47:230-237. DOI: 10.1016/j.avsg.2017.08.044. View

18.

Swaminathan G, Gadepalli V, Stoilov I, Mecham R, Rao R, Ramamurthi A . Pro-elastogenic effects of bone marrow mesenchymal stem cell-derived smooth muscle cells on cultured aneurysmal smooth muscle cells. J Tissue Eng Regen Med. 2014; 11(3):679-693. DOI: 10.1002/term.1964. View

19.

Fu X, Yamawaki-Ogata A, Oshima H, Ueda Y, Usui A, Narita Y . Intravenous administration of mesenchymal stem cells prevents angiotensin II-induced aortic aneurysm formation in apolipoprotein E-deficient mouse. J Transl Med. 2013; 11:175. PMC: 3726376. DOI: 10.1186/1479-5876-11-175. View

20.

Xie J, Jones T, Feng D, Cook T, Jester A, Yi R . Human Adipose-Derived Stem Cells Suppress Elastase-Induced Murine Abdominal Aortic Inflammation and Aneurysm Expansion Through Paracrine Factors. Cell Transplant. 2016; 26(2):173-189. PMC: 5657756. DOI: 10.3727/096368916X692212. View